News
GlobalData on MSN23h
Filament Health to supply psilocybin for two Phase II studiesFilament Health has collaborated with University College London (UCL) in the UK to provide its botanical psilocybin drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback